177 related articles for article (PubMed ID: 36386510)
1. The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis.
Liu J; Li Y; Zhang W; Yang C; Yang C; Chen L; Ding M; Zhang L; Liu X; Cui G; Liu Y
Front Surg; 2022; 9():971030. PubMed ID: 36386510
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis.
Zhu J; Xue Z; Zhang S; Guo X; Zhai L; Shang S; Zhang Y; Lu H
Int J Surg; 2018 Sep; 57():76-83. PubMed ID: 30103072
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of lymph node ratio for thyroid cancer: a meta-analysis.
Hu Y; Wang Z; Dong L; Zhang L; Xiuyang L
Front Oncol; 2024; 14():1333094. PubMed ID: 38384804
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis.
Li Y; Ma L
World J Surg Oncol; 2020 Dec; 18(1):316. PubMed ID: 33267822
[TBL] [Abstract][Full Text] [Related]
5. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
6. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
8. The Prognostic Significance of Lymph Node Ratio for Esophageal Cancer: A Meta-Analysis.
Song J; Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
J Surg Res; 2023 Dec; 292():53-64. PubMed ID: 37586187
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.
Visser E; Markar SR; Ruurda JP; Hanna GB; van Hillegersberg R
Ann Surg; 2019 Feb; 269(2):261-268. PubMed ID: 29794846
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
11. Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis.
Mechera R; Schuster T; Rosenberg R; Speich B
Eur J Cancer; 2017 Feb; 72():84-94. PubMed ID: 28027520
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
13. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis.
Zhang MR; Xie TH; Chi JL; Li Y; Yang L; Yu YY; Sun XF; Zhou ZG
Oncotarget; 2016 Nov; 7(45):72898-72907. PubMed ID: 27662659
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy.
Lai J; Pan Z; Chen P; Ye G; Chen K; Su F
Jpn J Clin Oncol; 2019 Jan; 49(1):22-28. PubMed ID: 30508184
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Yield in Gastrointestinal Cancer Surgery With or Without Prior Neoadjuvant Therapy: Protocol for a Systematic Review and Meta-analysis.
Ronellenfitsch U; Mathis N; Friedrichs J; Kleeff J
JMIR Res Protoc; 2022 Apr; 11(4):e35243. PubMed ID: 35482374
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
Ke L; Li S; Cui H
BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
[TBL] [Abstract][Full Text] [Related]
18. Platinum-Based Neoadjuvant Chemotherapy for Breast Cancer With BRCA Mutations: A Meta-Analysis.
Wang CJ; Xu Y; Lin Y; Zhu HJ; Zhou YD; Mao F; Zhang XH; Huang X; Zhong Y; Sun Q; Li CG
Front Oncol; 2020; 10():592998. PubMed ID: 33304851
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
[TBL] [Abstract][Full Text] [Related]
20. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
